Keyword search

Description: Previous research has found variability in cancer incidence and cancer-related outcomes according to place of residence. This study examined geographic variability in the incidence and mortality of breast cancer among females in Canada, using data from the 2021 Canadian Cancer Registry (breast cancer incidence) and the Canadian Vital Statistics – Death database (breast cancer mortality). Age-standardized incidence rates (ASIRs) and age-standardized mortality rates (ASMRs) per 100,000 females per year and their rate ratios were calculated, as well as age group-specific and age-standardized stage-specific incidence rates, and examined across provinces and territories, community sizes, and peer groups (i.e., clusters of health regions with similar socioeconomic and demographic characteristics).

Description: Breast cancer is the most commonly diagnosed cancer among women in Canada. Breast density substantially influences breast cancer risk and mammography performance. However, OncoSim-Breast, a Canadian microsimulation model representing breast cancer control, including cancer onset, screening, and survival, has not previously explicitly accounted for breast density. This study describes the incorporation of density-specific parameters—prevalence, relative risk of breast cancer, and digital mammography performance (sensitivity and specificity)—using data from five Canadian provinces, into the OncoSim-Breast model. Calibration experiments and internal validations were conducted to ensure the updated OncoSim-Breast model aligned with observed data from the Canadian Cancer Registry.

Description: This infographic explores trends in Canadians’ weight over time, as well as how obesity may impact health.

Description: Body mass index (BMI) is commonly used to estimate obesity prevalence; however, reliance on BMI alone can lead to an incomplete understanding of obesity’s impact on health. In line with the 2025 recommendations of the Lancet Diabetes & Endocrinology Commission, this study used measured and self-reported data from the 2016 to 2019 Canadian Health Measures Survey to combine population-level measures of excess adiposity with indicators of physiological dysfunction and activity limitation across eight body system domains. Clinical and preclinical obesity were characterized by excess adiposity and progressive obesity-related impairment among Canadian adults.

Description: Cardiovascular health measures of the household population, by sex and age group.

Description:

Number and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description:

The number of new cases, age-standardized rates and average age at diagnosis of cancers diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Cancer incidence rates are age-standardized using the direct method and the final 2011 Canadian postcensal population structure. Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description: Number of deaths caused by certain infectious and parasitic diseases, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by neoplasms, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by endocrine, nutritional and metabolic diseases, by age group and sex, 2000 to most recent year.

Description: Number and percentage of persons based on changes in body mass index between 1994/1995 and 2006/2007, 2008/2009 and 2010/2011, by age group and sex.

Description: Five-year relative survival ratios for all cancers combined for 1 year of cases from 1992 to 2003, by age group and sex, for Canada (excluding Quebec).

Description: Five-year relative survival ratios for all cancers combined for 3 years of cases from 1992 to 2001, by age group and sex, for Canada (excluding Quebec).

Description: Five-year relative survival ratios for breast cancer for 1 year of cases from 1992 to 2003, by age group and sex, for Canada (excluding Quebec).

Description: Five-year relative survival ratios for breast cancer for 3 years of cases from 1992 to 2001, by age group and sex, for Canada (excluding Quebec).

Description: Five-year relative survival ratios for prostate, gallbladder, ureter and chronic lymphocytic leukemia cancer for 1 year of cases from 1992 to 2003, by age group and sex, for Canada (excluding Quebec).

Description: Five-year relative survival ratios for prostate, gallbladder, ureter and chronic lymphocytic leukemia cancer for 3 years of cases from 1992 to 2001, by age group and sex, for Canada (excluding Quebec).

Description: Five-year relative survival ratios for selected cancers for 1 year of cases from 1992 to 2003, by age group and sex, for Canada (excluding Quebec).

Description: Five-year relative survival ratios for selected cancers for 3 years of cases from 1992 to 2001, by age group and sex, for Canada (excluding Quebec).

Description: Age-standardized five-year relative survival ratios for all cancers for 1 year of cases from 1992 to 2003, by sex, for Canada (excluding Quebec) and selected provinces.

Description: Certain population groups face a disproportionate burden of exposure to COVID-19. This study examined characteristics of Canadians living in private households in fall 2020 and winter 2021 who had been infected with COVID-19.

Description:

This study presents detailed tumour-based cancer prevalence estimates in Canada by sex, age group, cancer type and prevalence duration as of January 1, 2018.

Description: Reliance on the use of opioids to manage pain has increased over time, as have opioid-related morbidity and deaths. In 2019, Statistics Canada reported descriptive associations between demographic and geographic descriptors, certain mental health disorders, and problematic opioid pain relief medications (OPRM) use among Canada’s OPRM-using population aged 15 years or older. The goal of this analysis is to extend that previous research by using modelling to examine the associations for a broader range of characteristics. It strives to clarify which socioeconomic, health behaviour and psychosocial factors are independently and significantly associated with a greater likelihood of problematic OPRM use after accounting for other descriptors.

Description: Release published in The Daily – Statistics Canada’s official release bulletin

Description:

This document provides descriptive results of the muscle and bone density of the tibia. Descriptive results for lower limb muscle power and force are also presented.

Description:

Hypertension is a common condition experienced by close to one-quarter of the adult population in Canada. There is evidence that this condition or the medications used to treat it may lead to hearing health problems. The purpose of this study is to quantify associations between hypertension and hearing health problems—defined as having hearing loss, tinnitus or both conditions for adults aged 19 to 79 years. Data from cycles 3 (2012 to 2013) and 4 (2014 to 2015) of the Canadian Health Measures Survey are used.

Description:

This infographic provides information on the prevalence of hearing loss, tinnitus, or both conditions among Canadian adults. The prevalence of each condition is presented by sex and age group. Also included is the proportion who are unaware of their hearing loss.

Description:

This study is the first comprehensive evaluation of progress in cancer survival for all cancer types combined in Canada. The results span the complete time period of the Canadian Cancer Registry and are unaffected by changes in the age, sex and case-mix of cancers over this time. Specifically, predicted Canadian net cancer survival index (CSI) estimates for the three-year period from 2015 to 2017 are presented and compared with corresponding actual estimates dating as far back as the 1992-to-1994 period. Comparisons are made for both sexes combined and for males and females separately. Further insight is provided by the determination of the most influential cancer and sex combinations and the leading cancer types within each sex, in regard to changes in the CSI since the periods of 1992 to 1994 and 2005 to 2007.

Description:

Cancer incidence rates have been shown to vary by ethnicity, and the increasing awareness of and interest in reporting ethnic health inequalities have been growing internationally. The objective of this study was to assess cancer incidence and mortality rates by ethnicity in Canada. The study used the 2006 Canadian Census Health and Environment Cohort, linked to the Canadian Cancer Registry and the Canadian Vital Statistics-Death Database, to determine cancer cases and mortality from 2006 to 2016. Ethnicity was categorized as non-Indigenous North American (NINA); European; Caribbean; Latin, Central and South American (LCSA); African; East Asian; South Asian; and West Central Asian and Middle Eastern.

Description:

With data from the 2019 Canadian Community Health Survey, this study assessed the use of and exposure to handheld laser devices by Canadians and the potential associated health risks. In addition to the prevalence of handheld laser exposure or use, the frequency and type of injury sustained, and whether the injury was the result of personal use or someone else's use, the study also determined the type of handheld laser device being used and where the device was obtained.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The compendium of Canadian Cancer Registry procedures manuals set out the rules for reporting cancer data to the CCR for all provincial and territorial cancer registries.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The user guide to Death Clearance Feedback Reports is intended for users of the feedback reports. The feedback reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The Death Clearance Overview document describes the Death Clearance module of the Canadian Cancer Registry, its structure, its function and its role in the operation of the national cancer registry. Inputs and outputs are listed and briefly described, as well as the different steps constituting the Death Clearance process.

Description:

The Guidelines for Abstracting and Determining Death Certificate Only Cases are intended for use by all provincial and territorial cancer registries during their Death Clearance Process. The guidelines should be used when performing a comparison between the Death Certificate Notification and the cancer registry database.

Description:

This document examines the functional limitations, physical, emotional and social, related to the musculoskeletal conditions having the largest impact on the health of Canadians. These functional limitations are described and classified using the Classification and Measurement System of Functional Health (CLAMES).

These descriptions and classifications are the first step in a new approach to measuring the health of Canadians that examines what factors are adversely affecting population health and how to address them. This document also provides health professionals, advocacy groups, and individual Canadians with an overview of how living with certain musculoskeletal conditions affects day-to-day functioning.